Fibroblast Growth Factor-2-Mediated Protection of Cardiomyocytes From the Toxic Effects of Doxorubicin Requires the mTOR/Nrf-2/HO-1 Pathway
Oncotarget - United States
doi 10.18632/oncotarget.20558
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 27, 2017
Authors
Publisher
Impact Journals, LLC